*ST四环

000518 SZSE 证监会行业分类 C27医药制造业

Key Metrics

Market Cap

3.0B ($436.6M)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

204.0M

Net Income

-114.0M

Gross Margin

N/A

Op. Margin

-38.7%

Net Margin

-55.9%

ROE

-28.6%

ROA

-20.1%

D/E

0.42

Dividend Yield

N/A

EPS

-0.11

Current Ratio

3.34

Price History

Company Info

Industry	C27医药制造业
Market Segment	Main Board
Currency	CNY
Fiscal Year	2024

Business Overview

Jiangsu Sihuan Bioengineering Co., Ltd. engages in the pharmaceutical business in China. It offers delusheng and xindelusheng, an anti-tumor biotherapeutic drug for the treatment of kidney cancer, malignant melanoma, and cancerous chest and abdominal mass. It also engages in breeding and sales of flowers and seedlings; and landscaping projects. Jiangsu Sihuan Bioengineering Co., Ltd. was founded in 1992 and is headquartered in Jiangyin, China.

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About *ST四环

Ticker	000518
Exchange	SZSE
Sector	证监会行业分类
Industry	C27医药制造业